A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Conditions

• Platinum-resistant Ovarian Cancer
• Platinum-Resistant Fallopian Tube Carcinoma
• Platinum-Resistant Primary Peritoneal Carcinoma
• Clear Cell Adenocarcinoma of Ovary
• Clear Cell Adenocarcinoma of Vulva
• Clear Cell Adenocarcinoma of Vagina
• Clear Cell Adenocarcinoma of Cervix
• Clear Cell Adenocarcinoma of Uterus
• Clear Cell Adenocarcinoma of Fallopian Tube
• Clear Cell Adenocarcinoma of Peritoneum
• Endometrial Cancer

Interventions

• BIOLOGICAL: Lorigerlimab

Sponsor

MacroGenics